Top compounds associated with response to RBMY1F


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.15 0.001
mRNA GW843682X CTRPv2 pan-cancer AAC 0.11 0.002
mRNA MS-275 CTRPv2 pan-cancer AAC 0.095 0.003
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.1 0.004
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.092 0.006
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.11 0.006
mRNA GSK-J4 CTRPv2 pan-cancer AAC -0.27 0.009
Download CSV